Video

Decoding the Genome of Financial Crime: Innovating the Transformation of Money Laundering Discovery (Keynote Presentation)

02.09.2021 | By Mark Speyers
 

https://vimeo.com/536496439

 

It only took a year to develop a vaccine for a global health pandemic, but 20 years later, following huge investments and outlandish promises, we’re stuck in a losing status quo with no real progress in efficiently rooting out money laundering. Why?

Washing hands was not enough to stop COVID, and rules-based analytics are not enough to stop money laundering. Decoding the COVID genome stimulated collaboration and innovation for a vaccine in record time. Over the last year, Ayasdi pioneered a similar endeavor – to decode the genome of money laundering and tax evasion or the core behavioral indicators of crime. So what now if the opportunity existed for a profound transformation of the AML function, a material improvement of laundering discovery, and a resulting efficiency in cost?

Join Ayasdi to hear evidential and anecdotal insight on what a money laundering vaccine looks like, the mechanics of the challenges and opportunities we collectively face, and a pioneering, frictionless approach to ease the pain of the AML global business community.

Simon Moss

CEO
Symphony AyasdiAI

https://vimeo.com/536496439

 

It only took a year to develop a vaccine for a global health pandemic, but 20 years later, following huge investments and outlandish promises, we’re stuck in a losing status quo with no real progress in efficiently rooting out money laundering. Why?

Washing hands was not enough to stop COVID, and rules-based analytics are not enough to stop money laundering. Decoding the COVID genome stimulated collaboration and innovation for a vaccine in record time. Over the last year, Ayasdi pioneered a similar endeavor – to decode the genome of money laundering and tax evasion or the core behavioral indicators of crime. So what now if the opportunity existed for a profound transformation of the AML function, a material improvement of laundering discovery, and a resulting efficiency in cost?

Join Ayasdi to hear evidential and anecdotal insight on what a money laundering vaccine looks like, the mechanics of the challenges and opportunities we collectively face, and a pioneering, frictionless approach to ease the pain of the AML global business community.

Simon Moss

CEO
Symphony AyasdiAI

Latest Insights

 
02.26.2024 Blog

Lacking Data and Tools: The 8 Barriers to OTT Insights

Media
Purpose-built vertical AI—SymphonyAI’s unique strategy for vertical SaaS industry solutions
 
02.26.2024 Blog

Purpose-Built Vertical AI—SymphonyAI’s Unique Strategy for Vertical SaaS Industry Solutions

SymphonyAI
SymphonyAI’s Gen AI-First Design Evolution
 
02.23.2024 Blog

SymphonyAI’s Gen AI-First Design Evolution

SymphonyAI